Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy

Immune Network
Seongju Jeong, Su-Hyung Park

Abstract

Immune checkpoint inhibitors (ICIs), including anti-PD-1 and anti-CTLA-4 therapeutic agents, are now approved by the Food and Drug Administration for treatment of various types of cancer. However, the therapeutic efficacy of ICIs varies among patients and cancer types. Moreover, most patients do not develop durable antitumor responses after ICI therapy due to an ephemeral reversal of T-cell dysfunction. As co-stimulatory receptors play key roles in regulating the effector functions of T cells, activating co-stimulatory pathways may improve checkpoint inhibition efficacy, and lead to durable antitumor responses. Here, we review recent advances in our understating of co-stimulatory receptors in cancers, providing the necessary groundwork for the rational design of cancer immunotherapy.

References

Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P S LinsleyJ A Ledbetter
Jun 10, 1998·The Journal of Experimental Medicine·K SaoulliT H Watts
Nov 25, 1998·Seminars in Immunology·D S Vinay, B S Kwon
Oct 25, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·A J McAdamG J Freeman
May 15, 2003·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Bruce L MusgraveDavid W Hoskin
Jun 27, 2003·Cancer Immunology, Immunotherapy : CII·Takashi TsukishiroTheresa L Whiteside
Jan 20, 2004·Nature Immunology·Jianxun SongMichael Croft
Feb 5, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrea LadányiJózsef Tímár
Feb 28, 2004·The Journal of Biological Chemistry·Patricia A ValdezIqbal S Grewal
May 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ruediger M FlaigCarsten Watzl
Jun 3, 2004·Nature Reviews. Immunology·Kazuo SugamuraAndrew D Weinberg
Mar 29, 2005·Nature Immunology·Jennifer Hartt MeyersVijay K Kuchroo
May 13, 2005·Cancer Immunology, Immunotherapy : CII·Javier G CasadoRaquel Tarazona
Aug 16, 2006·The New England Journal of Medicine·Ganesh SuntharalingamNicki Panoskaltsis
Aug 23, 2006·Proceedings of the National Academy of Sciences of the United States of America·Tomoki ItoYong-Jun Liu
Dec 15, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Daniela DrenkardHerbert Schwarz
Sep 20, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Gilberto FilaciFrancesco Indiveri
Dec 15, 2007·The Journal of Clinical Investigation·Nicolas DegauqueTerry B Strom
Mar 26, 2008·The Journal of Experimental Medicine·Silvia PiconeseMario P Colombo
May 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jianxun SongMichael Croft
Oct 4, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yifan ZhanAndrew M Lew
Nov 20, 2008·Cancer Immunology, Immunotherapy : CII·John S ChoSherie L Morrison
Nov 26, 2008·The Journal of Experimental Medicine·Susan GilfillanMarco Colonna
May 12, 2009·Immunological Reviews·Christopher E RuddHelga Schneider
Sep 18, 2009·Advances in Experimental Medicine and Biology·Giuseppe Nocentini, Carlo Riccardi
Mar 5, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lawrence P Kane
Jun 1, 2010·Advances in Immunology·Naoto IshiiKazuo Sugamura
Nov 16, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Laura M SnellTania H Watts
Apr 7, 2011·European Journal of Immunology·Sheng XiaoVijay K Kuchroo
Jun 30, 2011·Immunology·Marius StriogaDainius Characiejus

❮ Previous
Next ❯

Citations

Mar 16, 2021·Frontiers in Immunology·Yun-Shiuan Olivia HsuChun-Bing Chen
Jul 13, 2021·Signal Transduction and Targeted Therapy·Huakan ZhaoYongsheng Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.